Dysregulation of DCUN1D1, the neddylation pathway and cullin RING ligases’ (CRLs) activity can affect the degradation of specific proteins involved in cellular processes, contributing to oncogenesis, tumour growth and resistance to therapies. The gene discussed is DCUN1D1; the disease is neoplasm.